Europe Telehealth Market
Marktgröße in Milliarden USD
CAGR :
% 
 Prognosezeitraum |
2024 –2031 |
 Marktgröße (Basisjahr) | USD 8.73 Million |
 Marktgröße (Prognosejahr) | USD 29.18 Million |
 CAGR |
% |
| Wichtige Marktteilnehmer |
|
Europäischer Telemedizinmarkt nach Komponenten (Hardware, Telekommunikation/Dienste, Software und integrierte Systeme), Bereitstellungsmodus (Cloud-basierter Bereitstellungsmodus, webbasierter Bereitstellungsmodus und Vor-Ort-Liefermodus), Kaufmodus (Gruppenkauf und Einzelkauf), Anwendung (Allgemeine Beratung, Pathologie, Neurologie, Kardiologie, Dermatologie, Chirurgie, Gynäkologie, Orthopädie, Augenheilkunde, Radiologie und andere), Endbenutzer (Telemedizin im Krankenhaus, Telemedizin für Ärzte, Telemedizin zu Hause und andere) – Branchentrends und Prognose bis 2031.
Analyse und Einblicke zum europäischen Telemedizin-Markt
Nach Angaben der European Chronic Disease Alliance sterben in Europa jährlich 3,9 Millionen Menschen an Herz-Kreislauf-Erkrankungen (CVD). In der Europäischen Union (EU) sind davon über 1,8 Millionen Todesfälle zu verzeichnen. CVD ist für 45 % aller Todesfälle in Europa verantwortlich und macht 37 % aller Todesfälle in der Europäischen Union aus.
Laut einer Analyse von Data Bridge Market Research dürfte der europäische Telemedizinmarkt von 8,73 Milliarden US-Dollar im Jahr 2023 auf 29,18 Milliarden US-Dollar im Jahr 2031 anwachsen und im Prognosezeitraum zwischen 2024 und 2031 eine durchschnittliche jährliche Wachstumsrate (CAGR) von 16,7 % aufweisen.
|
Berichtsmetrik |
Details |
|
Prognosezeitraum |
2024 bis 2031 |
|
Basisjahr |
2023 |
|
Historische Jahre |
2022 (anpassbar auf 2016–2021) |
|
Quantitative Einheiten |
Umsatz in Milliarden USD |
|
Abgedeckte Segmente |
Komponente (Hardware, Telekommunikation/Dienste, Software und integrierte Systeme), Liefermodus (Cloud-basierter Liefermodus, webbasierter Liefermodus und Vor-Ort-Liefermodus), Kaufmodus (Gruppenkauf und Einzelkauf), Anwendung (Allgemeine Beratung, Pathologie, Neurologie, Kardiologie, Dermatologie, Chirurgie, Gynäkologie, Orthopädie, Augenheilkunde , Radiologie und andere), Endbenutzer (Telemedizin im Krankenhaus, Telemedizin für Ärzte, Telemedizin zu Hause und andere |
|
Abgedeckte Länder |
Großbritannien, Deutschland, Italien, Frankreich, Spanien, Schweiz, Russland, Niederlande, Türkei, Belgien und Rest von Europa |
|
Abgedeckte Marktteilnehmer |
Teladoc Health, Inc., Medtronic, Koninklijke Philips NV, Honeywell International Inc., Siemens Healthineers AG, F. Hoffmann-La Roche Ltd., AMN Healthcare Services Inc., darunter American Well (Amwell), Oracle, GCX Corporation, Aerotel Medical Systems Ltd., GE Healthcare, AMD Europe Telemedicine und Omron Healthcare Inc. |
Marktdefinition
Telehealth denotes the provision of healthcare services and medical information using telecommunications and digital technology. This encompasses a broad range of remote healthcare services, including virtual consultations, remote monitoring of patients, teletherapy, telepharmacy, and telemedicine. Through telehealth, patients can access medical care, advice, and treatment from healthcare providers remotely, often from the comfort of their own homes. This innovative approach improves access to healthcare, particularly for those in rural or underserved areas, and enhances the efficiency of care delivery. Telehealth has gained significant popularity due to its convenience, cost-effectiveness, and potential to improve health outcomes by enabling timely and accessible medical support.
Europe Telehealth Market Dynamics
This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers
- Growing Prevalence of Chronic Diseases and Conditions
Chronic diseases such as cardiovascular diseases, diabetes, and respiratory illnesses require ongoing management and monitoring, often involving frequent visits to healthcare providers. Telehealth offers a suitable and cost-effective way to manage these conditions remotely, allowing patients to receive care without the need for frequent in-person visits.
Telehealth platforms can enable patients to monitor their vital signs, track their symptoms, and communicate with healthcare providers from their homes. This not only improves convenience for patients but also allows healthcare providers to monitor patients more closely and intervene early if any issues arise. Additionally, telehealth can help reduce healthcare costs associated with chronic disease management, as it can reduce the need for hospitalizations and emergency room visits.
- Accessible and Widely Adopted M-Health Applications
Mobile health applications, often available on smartphones and tablets, allow patients to access healthcare services and information remotely. They can facilitate various telehealth services, such as virtual consultations with healthcare providers, remote monitoring of vital signs, and medication reminders. The widespread adoption of smartphones and tablets worldwide has made it easier for patients to access mHealth applications, regardless of their location. This increased accessibility has expanded the reach of telehealth services, especially in rural or underserved areas where access to traditional healthcare facilities may be limited.
Furthermore, the user-friendly interfaces and functionalities of mHealth applications have contributed to their widespread adoption among patients. These applications are often designed to be intuitive and easy to use, allowing patients to manage their health more effectively and engage with telehealth services more readily.
Restraint
- High Cost Associated with Healthcare IT Tools
The high cost associated with healthcare IT tools is a significant restraint on the Europe telehealth market. Implementing telehealth services requires substantial investment in systems, software, and hardware, which can be a barrier for many healthcare providers, especially those with limited financial resources. The cost of acquiring, implementing, and maintaining telehealth systems, software, and hardware can be prohibitively high, preventing some healthcare organizations from adopting telehealth solutions. Additionally, the complexity of integrating these IT tools with existing healthcare systems and ensuring interoperability can further increase costs. Training healthcare professionals to effectively use these tools also adds to the overall cost of implementing telehealth services.
Opportunity
- Growing Expansion of Telehealth Application
The expansion of telehealth services and the increased use of remote consultations are opening up new opportunities for telehealth market players. Telehealth platforms enable healthcare providers to assess patients remotely, provide guidance, and monitor treatment progress, offering greater accessibility and convenience for patients with musculoskeletal conditions. By eliminating geographical barriers and making healthcare more widely available, telehealth can reach patients who might otherwise face challenges accessing medical care due to distance or limited healthcare infrastructure. This growing access allows telehealth companies to cater to a broader patient base and expand their offerings. With real-time monitoring through video consultations, secure messaging, and remote monitoring devices, healthcare professionals can keep track of patients' vital signs, progress, and conditions without needing in-person visits. The seamless integration of health monitoring tools into telehealth platforms also supports personalized care management, making it easier for healthcare providers to offer high-quality, continuous care to patients. This trend presents a significant opportunity for telehealth market players to enhance their services and grow their market share.
Challenge
- Software Incompatibility Issues Due to Varying Data Standards
In the evolving landscape of the Telehealth market, the integration and exchange of data among diverse software systems, including electronic health records (EHRs), remote monitoring platforms, and healthcare provider systems, pose significant challenges. The lack of standardized data formats and protocols leads to interoperability issues, hindering effective communication and data sharing. This disparity among software systems results in fragmented information, impeding the seamless flow of data crucial for monitoring. Furthermore, the integration of data from various sources, such as wearable devices and electronic medical records, encounters hurdle due to differing proprietary formats. This complexity in consolidating and analyzing data hampers the efficiency of digital therapeutic solutions, contributing to implementation delays, increased costs, and obstacles in market growth.
Recent Developments
- In August 2023, Fresenius SE & Co. KGaA announced the FDA's 510(k) clearance for Versi HD with GuideMe Software, a fully redesigned self-guided interface for the company's VersiHD chronic home hemodialysis (HHD) equipment. The goal of VersiHD with GuideMe Software is to change how nurses and patients see HHD. This helped the company to expand its product line with availability in the market
- In April 2023, Medtronic and DaVita Inc. jointly launched Mozarc Medical, an independent company dedicated to transforming kidney health and advancing patient-centered technology solutions
- In January 2022, Evoqua Water Technologies LLC finalized the acquisition of the renal business formerly operated by Mar Cor Purification, a subsidiary of STERIS Plc. This acquisition will broaden Evoqua's service presence in North America, strengthening its position in the healthcare sector
- In December 2021, ExThera Medical and Asahi Kasei Medical Co., Ltd., a core operating company of the Asahi Kasei Group, signed an exclusive distribution agreement in Japan for ExThera's Seraph 100 Microbind Affinity Blood Filter (Seraph 100). Under the agreement, ExThera Medical and Asahi Kasei Medical Co., Ltd. collaborated to secure regulatory approval of Seraph 100 for commercialization in Japan. This agreement, as a significant step, helped the company in the expansion of the intensive care business field
Europe Telehealth Market Scope
The Europe telehealth market is segmented into five notable segments based on component, delivery mode, mode of purchase, application, and end user.
The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the differences in your target markets.
Component
- Hardware
- Telecommunication/Services
- Software
- Integrated Systems
On the basis of component, the market is segmented into hardware, telecommunication/ services, software and integrated systems.
Delivery Mode
- Cloud-Based Delivery Mode
- Web-Based Delivery Mode
- On-Premise Delivery Mode
Auf der Grundlage der Lieferart ist der Markt in die Lieferart Cloud-basiert, die Lieferart Web-basiert und die Lieferart Vor-Ort segmentiert.
Kaufart
- Gruppenkauf
- Einzelkauf
Auf der Grundlage der Kaufart wird der Markt in Gruppenkäufe und Einzelkäufe segmentiert.
Anwendung
- Allgemeine Beratung
- Pathologie
- Neurologie
- Kardiologie
- Dermatologie
- Operation
- Gynäkologie
- Orthopädie
- Augenheilkunde
- Radiologie
- Sonstiges
Auf der Grundlage der Anwendung ist der Markt in allgemeine Beratung, Pathologie, Neurologie, Kardiologie, Dermatologie, Chirurgie, Gynäkologie, Orthopädie, Augenheilkunde, Radiologie und andere unterteilt.
Endbenutzer
- Telemedizin im Krankenhaus
- Telemedizin für Ärzte
- Telemedizin für Zuhause
- Sonstiges
Auf der Grundlage des Endbenutzers ist der Markt in Telemedizin im Krankenhaus, Telemedizin beim Arzt, Telemedizin zu Hause und andere segmentiert.
Regionale Analyse/Einblicke zum europäischen Telemedizinmarkt
Der europäische Telemedizinmarkt ist basierend auf Komponente, Liefermodus, Kaufart, Anwendung und Endbenutzer in fünf wichtige Segmente unterteilt.
Die in diesem Marktbericht abgedeckten Länder sind Großbritannien, Deutschland, Italien, Frankreich, Spanien, die Schweiz, Russland, die Niederlande, die Türkei, Belgien und das übrige Europa.
Aufgrund der Einführung fortschrittlicher Technologien, der robusten Gesundheitsinfrastruktur und des reifen Marktes wird Großbritannien voraussichtlich die Region Europa dominieren.
Der Länderabschnitt des Berichts enthält auch Angaben zu einzelnen marktbeeinflussenden Faktoren und Änderungen der Regulierung auf dem Inlandsmarkt, die sich auf die aktuellen und zukünftigen Markttrends auswirken. Datenpunkte wie Neuverkäufe, Ersatzverkäufe, demografische Daten des Landes, Regulierungsgesetze und Import-/Exportzölle sind einige der wichtigsten Anhaltspunkte, die zur Prognose des Marktszenarios für einzelne Länder verwendet werden. Bei der Prognoseanalyse der Länderdaten werden auch die Präsenz und Verfügbarkeit europäischer Marken und ihre Herausforderungen aufgrund großer oder geringer Konkurrenz durch lokale und inländische Marken sowie die Auswirkungen der Vertriebskanäle berücksichtigt.
Wettbewerbsumfeld und Marktanteilsanalyse für Telemedizin in Europa
Die Wettbewerbslandschaft des europäischen Telemedizinmarktes liefert Einzelheiten zu den Wettbewerbern. Zu den enthaltenen Einzelheiten gehören Unternehmensübersicht, Unternehmensfinanzen, erzielter Umsatz, Marktpotenzial, Investitionen in Forschung und Entwicklung, neue Marktinitiativen, Produktionsstandorte und -anlagen, Stärken und Schwächen des Unternehmens, Produkteinführung, Produktzulassungen, Produktbreite und -umfang, Anwendungsdominanz und Produkttyp-Lebenslinienkurve. Die oben angegebenen Datenpunkte beziehen sich nur auf den Fokus des Unternehmens auf dem Markt.
Zu den wichtigsten Marktteilnehmern auf dem Markt zählen unter anderem Teladoc Health, Inc., Medtronic, Koninklijke Philips NV, Honeywell International Inc., Siemens Healthineers AG, F. Hoffmann-La Roche Ltd., AMN Healthcare Services Inc., Included American Well (Amwell), Oracle, GCX Corporation, Aerotel Medical Systems Ltd., GE Healthcare, AMD Europe Telemedicine und Omron Healthcare Inc.
SKU-
Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud
- Interaktives Datenanalyse-Dashboard
- Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
- Zugriff für Research-Analysten für Anpassungen und Abfragen
- Konkurrenzanalyse mit interaktivem Dashboard
- Aktuelle Nachrichten, Updates und Trendanalyse
- Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Inhaltsverzeichnis
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE EUROPE TELEHEALTH MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 PRODUCT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 STRATEGIC DECISIONS
4.2 FOUR SEGMENTS COMPRISE THE EUROPE TELEHEALTH MARKET, BY COMPOMENT
4.3 PESTEL ANALYSIS
4.4 PORTER’S FIVE FORCES
5 REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 GROWING PREVALENCE OF CHRONIC DISEASES AND CONDITIONS
6.1.2 ACCESSIBLE AND WIDELY ADOPTED MHEALTH APPLICATIONS
6.1.3 GROWING DEMAND FOR TELEHEALTH IN RURAL AREA
6.2 RESTRAINTS
6.2.1 HIGH COST ASSOCIATED WITH HEALTHCARE IT TOOLS
6.2.2 INADEQUATE OR INCONSISTENT REIMBURSEMENT POLICIES
6.2.3 STRINGENT REGULATORY FRAMEWORK
6.3 OPPORTUNITIES
6.3.1 GROWING EXPANSION OF TELEHEALTH APPLICATION
6.3.2 INCREASING FOCUS ON PERSONALIZED DEVICES FOR USERS
6.3.3 INCREASING AWARENESS AMONG PEOPLE
6.4 CHALLENGES
6.4.1 SOFTWARE INCOMPATIBILITY ISSUES DUE TO VARYING DATA STANDARDS
6.4.2 RISKS OF CYBER ATTACKS ON TELEHEALTH PLATFORMS, COMPROMISING PATIENT PRIVACY
7 EUROPE TELEHEALTH MARKET, BY COMPONENT
7.1 OVERVIEW
7.2 HARDWARE
7.2.1 MEDICAL PERIPHERAL DEVICES
7.2.1.1 BLOOD PRESSURE MONITORS
7.2.1.2 BLOOD GLUCOSE METERS
7.2.1.3 PULSE OXIMETERS
7.2.1.4 ECG MONITORS
7.2.1.5 WEIGHT SCALES
7.2.1.6 PEAK FLOW METERS
7.2.1.7 OTHERS
7.2.2 DEVICE POSITIONING SOLUTIONS
7.2.2.1 TABLET ARM
7.2.2.2 TABLE UPGRADE KIT
7.2.2.3 COMPACT TABLES
7.2.2.4 OVERBED TABLES
7.2.2.5 SURFACE MOUNTS
7.2.2.6 RAIL MOUNTS
7.2.2.7 OTHERS
7.2.3 MONITORS
7.2.4 OTHERS
7.2.5 MOBILE
7.2.5.1 CART BASED
7.2.5.1.1 VARIABLE HEIGHT
7.2.5.1.2 FIXED HEIGHT
7.2.5.2 ROLLS STAND BASED
7.2.5.2.1 VARIABLE HEIGHT
7.2.5.2.2 FIXED HEIGHT
7.2.6 FIXED
7.2.6.1 CHANNEL/WALL
7.2.6.2 COUNTER TOP
7.2.6.3 POST/POLE
7.2.6.4 OTHERS
7.3 TELECOMMUNICATION/SERVICES
7.4 SOFTWARE
7.4.1 INTEGRATED SOFTWARE
7.4.2 STANDALONE SOFTWARE
7.5 INTEGRATED SYSTEMS
8 EUROPE TELEHEALTH MARKET, BY DELIVERY MODE
8.1 OVERVIEW
8.2 CLOUD-BASED DELIVERY
8.3 WEB-BASED DELIVERY
8.4 ON-PREMISE DELIVERY MODE
9 EUROPE TELEHEALTH MARKET, BY MODE OF PURCHASE
9.1 OVERVIEW
9.2 GROUP PURCHASE
9.3 INDIVIDUAL PURCHASE
10 EUROPE TELEHEALTH MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 GENERAL CONSULTATION
10.3 PATHOLOGY
10.4 NEUROLOGY
10.5 CARDIOLOGY
10.6 DERMATOLOGY
10.7 SURGERY
10.8 GYNECOLOGY
10.9 ORTHOPEDICS
10.1 OPHTHALMOLOGY
10.11 RADIOLOGY
10.12 OTHERS
11 EUROPE TELEHEALTH MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITAL TELEHEALTH
11.3 PHYSICIAN TELEHEALTH
11.4 HOME TELEHEALTH
11.5 OTHERS
12 EUROPE TELEHEALTH MARKET, BY COUNTRY
12.1 EUROPE
12.1.1 U.K.
12.1.2 GERMANY
12.1.3 ITALY
12.1.4 FRANCE
12.1.5 SPAIN
12.1.6 SWITZERLAND
12.1.7 RUSSIA
12.1.8 NETHERLANDS
12.1.9 TURKEY
12.1.10 BELGIUM
12.1.11 REST OF EUROPE
13 EUROPE TELEHEALTH MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: EUROPE
14 SWOT ANALYSIS
15 COMPANY PROFILE
15.1 KONINKLIJKE PHILIPS N.V.,
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 PRODUCT PORTFOLIO
15.1.4 RECENT DEVELOPMENT
15.2 MEDTRONIC
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 PRODUCT PORTFOLIO
15.2.4 RECENT DEVELOPMENT
15.3 HONEYWELL INTERNATIONAL INC.
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 PRODUCT PORTFOLIO
15.3.4 RECENT DEVELOPMENT
15.4 TELADOC HEALTH, INC.
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 PRODUCT PORTFOLIO
15.4.4 RECENT DEVELOPMENTS
15.5 AEROTEL MEDICAL SYSTEMS
15.5.1 COMPANY SNAPSHOT
15.5.2 PRODUCT PORTFOLIO
15.5.3 RECENT DEVELOPMENT
15.6 AMERICAN WELL
15.6.1 COMPANY SNAPSHOT
15.6.2 8.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT DEVELOPMENTS
15.7 AMN HEALTHCARE
15.7.1 COMPANY SNAPSHOT
15.7.2 REVENUE ANALYSIS
15.7.3 PRODUCT PORTFOLIO
15.7.4 RECENT DEVELOPMENTS
15.8 F. HOFFMANN-LA ROCHE LTD
15.8.1 COMPANY SNAPSHOT
15.8.2 REVENUE ANALYSIS
15.8.3 PRODUCT PORTFOLIO
15.8.4 RECENT DEVELOPMENT
15.9 GCX CORPORATION
15.9.1 COMPANY SNAPSHOT
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT DEVLOPMENT
15.1 GE HEALTHCARE
15.10.1 COMPANY SNAPSHOT
15.10.2 REVENUE ANALYSIS
15.10.3 PRODUCT PORTFOLIO
15.10.4 RECENT DEVELOPMENT
15.11 OMRON HEALTHCARE, INC.
15.11.1 COMPANY SNAPSHOT
15.11.2 PRODUCT PORTFOLIO
15.11.3 RECENT DEVELOPMENTS
15.12 ORACLE
15.12.1 COMPANY SNAPSHOT
15.12.2 REVENUE ANALYSIS
15.12.3 SERVICE PORTFOLIO
15.12.4 RECENT DEVELOPMENTS
15.13 SIEMENS HEALTHCARE GMBH
15.13.1 COMPANY SNAPSHOT
15.13.2 REVENUE ANALYSIS
15.13.3 PRODUCT PORTFOLIO
15.13.4 RECENT DEVELOPMENT
16 QUESTIONNAIRE
17 RELATED REPORTS
Tabellenverzeichnis
TABLE 1 EUROPE TELEHEALTH MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABLE 2 EUROPE HARDWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 3 EUROPE MEDICAL PERIPHERAL DEVICES IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 4 EUROPE DEVICE POSITIONING SOLUTIONS IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 5 EUROPE HARDWARE IN TELEHEALTH MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 6 EUROPE MOBILE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 7 EUROPE CART BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 8 EUROPE ROLLS STAND BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 9 EUROPE FIXED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 10 EUROPE SOFTWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 11 EUROPE TELEHEALTH MARKET, BY DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 12 EUROPE TELEHEALTH MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 13 EUROPE TELEHEALTH MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 14 EUROPE TELEHEALTH MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 15 EUROPE TELEHEALTH MARKET, 2022-2031 (USD MILLION)
TABLE 16 EUROPE TELEHEALTH MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABLE 17 EUROPE HARDWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 18 EUROPE MEDICAL PERIPHERAL DEVICES IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 19 EUROPE DEVICE POSITIONING SOLUTIONS IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 20 EUROPE HARDWARE IN TELEHEALTH MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 21 EUROPE MOBILE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 22 EUROPE CART BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 23 EUROPE ROLLS STAND BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 24 EUROPE FIXED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 25 EUROPE SOFTWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 26 EUROPE TELEHEALTH MARKET, BY DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 27 EUROPE TELEHEALTH MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 28 EUROPE TELEHEALTH MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 29 EUROPE TELEHEALTH MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 30 U.K. TELEHEALTH MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABLE 31 U.K. HARDWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 32 U.K. MEDICAL PERIPHERAL DEVICES IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 33 U.K. DEVICE POSITIONING SOLUTIONS IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 34 U.K. HARDWARE IN TELEHEALTH MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 35 U.K. MOBILE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 36 U.K. CART BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 37 U.K. ROLLS STAND BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 38 U.K. FIXED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 39 U.K. SOFTWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 40 U.K. TELEHEALTH MARKET, BY DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 41 U.K. TELEHEALTH MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 42 U.K. TELEHEALTH MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 43 U.K. TELEHEALTH MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 44 GERMANY TELEHEALTH MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABLE 45 GERMANY HARDWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 46 GERMANY MEDICAL PERIPHERAL DEVICES IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 47 GERMANY DEVICE POSITIONING SOLUTIONS IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 48 GERMANY HARDWARE IN TELEHEALTH MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 49 GERMANY MOBILE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 50 GERMANY CART BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 51 GERMANY ROLLS STAND BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 52 GERMANY FIXED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 53 GERMANY SOFTWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 54 GERMANY TELEHEALTH MARKET, BY DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 55 GERMANY TELEHEALTH MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 56 GERMANY TELEHEALTH MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 57 GERMANY TELEHEALTH MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 58 ITALY TELEHEALTH MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABLE 59 ITALY HARDWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 60 ITALY MEDICAL PERIPHERAL DEVICES IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 61 ITALY DEVICE POSITIONING SOLUTIONS IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 62 ITALY HARDWARE IN TELEHEALTH MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 63 ITALY MOBILE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 64 ITALY CART BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 65 ITALY ROLLS STAND BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 66 ITALY FIXED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 67 ITALY SOFTWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 68 ITALY TELEHEALTH MARKET, BY DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 69 ITALY TELEHEALTH MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 70 ITALY TELEHEALTH MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 71 ITALY TELEHEALTH MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 72 FRANCE TELEHEALTH MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABLE 73 FRANCE HARDWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 74 FRANCE MEDICAL PERIPHERAL DEVICES IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 75 FRANCE DEVICE POSITIONING SOLUTIONS IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 76 FRANCE HARDWARE IN TELEHEALTH MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 77 FRANCE MOBILE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 78 FRANCE CART BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 79 FRANCE ROLLS STAND BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 80 FRANCE FIXED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 81 FRANCE SOFTWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 82 FRANCE TELEHEALTH MARKET, BY DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 83 FRANCE TELEHEALTH MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 84 FRANCE TELEHEALTH MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 85 FRANCE TELEHEALTH MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 86 SPAIN TELEHEALTH MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABLE 87 SPAIN HARDWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 88 SPAIN MEDICAL PERIPHERAL DEVICES IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 89 SPAIN DEVICE POSITIONING SOLUTIONS IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 90 SPAIN HARDWARE IN TELEHEALTH MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 91 SPAIN MOBILE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 92 SPAIN CART BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 93 SPAIN ROLLS STAND BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 94 SPAIN FIXED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 95 SPAIN SOFTWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 96 SPAIN TELEHEALTH MARKET, BY DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 97 SPAIN TELEHEALTH MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 98 SPAIN TELEHEALTH MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 99 SPAIN TELEHEALTH MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 100 SWITZERLAND TELEHEALTH MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABLE 101 SWITZERLAND HARDWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 102 SWITZERLAND MEDICAL PERIPHERAL DEVICES IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 103 SWITZERLAND DEVICE POSITIONING SOLUTIONS IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 104 SWITZERLAND HARDWARE IN TELEHEALTH MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 105 SWITZERLAND MOBILE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 106 SWITZERLAND CART BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 107 SWITZERLAND ROLLS STAND BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 108 SWITZERLAND FIXED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 109 SWITZERLAND SOFTWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 110 SWITZERLAND TELEHEALTH MARKET, BY DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 111 SWITZERLAND TELEHEALTH MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 112 SWITZERLAND TELEHEALTH MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 113 SWITZERLAND TELEHEALTH MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 114 RUSSIA TELEHEALTH MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABLE 115 RUSSIA HARDWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 116 RUSSIA MEDICAL PERIPHERAL DEVICES IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 117 RUSSIA DEVICE POSITIONING SOLUTIONS IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 118 RUSSIA HARDWARE IN TELEHEALTH MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 119 RUSSIA MOBILE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 120 RUSSIA CART BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 121 RUSSIA ROLLS STAND BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 122 RUSSIA FIXED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 123 RUSSIA SOFTWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 124 RUSSIA TELEHEALTH MARKET, BY DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 125 RUSSIA TELEHEALTH MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 126 RUSSIA TELEHEALTH MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 127 RUSSIA TELEHEALTH MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 128 NETHERLANDS TELEHEALTH MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABLE 129 NETHERLANDS HARDWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 130 NETHERLANDS MEDICAL PERIPHERAL DEVICES IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 131 NETHERLANDS DEVICE POSITIONING SOLUTIONS IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 132 NETHERLANDS HARDWARE IN TELEHEALTH MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 133 NETHERLANDS MOBILE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 134 NETHERLANDS CART BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 135 NETHERLANDS ROLLS STAND BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 136 NETHERLANDS FIXED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 137 NETHERLANDS SOFTWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 138 NETHERLANDS TELEHEALTH MARKET, BY DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 139 NETHERLANDS TELEHEALTH MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 140 NETHERLANDS TELEHEALTH MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 141 NETHERLANDS TELEHEALTH MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 142 TURKEY TELEHEALTH MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABLE 143 TURKEY HARDWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 144 TURKEY MEDICAL PERIPHERAL DEVICES IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 145 TURKEY DEVICE POSITIONING SOLUTIONS IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 146 TURKEY HARDWARE IN TELEHEALTH MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 147 TURKEY MOBILE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 148 TURKEY CART BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 149 TURKEY ROLLS STAND BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 150 TURKEY FIXED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 151 TURKEY SOFTWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 152 TURKEY TELEHEALTH MARKET, BY DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 153 TURKEY TELEHEALTH MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 154 TURKEY TELEHEALTH MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 155 TURKEY TELEHEALTH MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 156 BELGIUM TELEHEALTH MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABLE 157 BELGIUM HARDWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 158 BELGIUM MEDICAL PERIPHERAL DEVICES IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 159 BELGIUM DEVICE POSITIONING SOLUTIONS IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 160 BELGIUM HARDWARE IN TELEHEALTH MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 161 BELGIUM MOBILE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 162 BELGIUM CART BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 163 BELGIUM ROLLS STAND BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 164 BELGIUM FIXED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 165 BELGIUM SOFTWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 166 BELGIUM TELEHEALTH MARKET, BY DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 167 BELGIUM TELEHEALTH MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 168 BELGIUM TELEHEALTH MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 169 BELGIUM TELEHEALTH MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 170 REST OF EUROPE TELEHEALTH MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
Abbildungsverzeichnis
FIGURE 1 EUROPE TELEHEALTH MARKET: SEGMENTATION
FIGURE 2 EUROPE TELEHEALTH MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE TELEHEALTH MARKET: DROC ANALYSIS
FIGURE 4 EUROPE TELEHEALTH MARKET : EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE TELEHEALTH MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE TELEHEALTH MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE TELEHEALTH MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 EUROPE TELEHEALTH MARKET: DBMR MARKET POSITION GRID
FIGURE 9 EUROPE TELEHEALTH MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE TELEHEALTH MARKET: SEGMENTATION
FIGURE 11 EXECUTIVE SUMMARY OF EUROPE TELEHEALTH MARKET
FIGURE 12 GROWING PREVALENCE OF CHRONIC DISEASES AND CONDITIONS IS DRIVING THE GROWTH OF THE EUROPE TELEHEALTH MARKET FROM 2024 TO 2031
FIGURE 13 THE CATEGORY SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE TELEHEALTH MARKET IN 2024 AND 2031
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF ASIA-PACIFIC OFFSITE STERILISATION SERVICE MARKET
FIGURE 15 EUROPE TELEHEALTH MARKET: BY COMPONENT 2023
FIGURE 16 EUROPE TELEHEALTH MARKET: BY COMPONENT, 2024-2031 (USD MILLION)
FIGURE 17 EUROPE TELEHEALTH MARKET: BY COMPONENT, CAGR (2024-2031)
FIGURE 18 EUROPE TELEHEALTH MARKET: BY COMPONENT, LIFELINE CURVE
FIGURE 19 EUROPE TELEHEALTH MARKET: BY DELIVERY MODE, 2023
FIGURE 20 EUROPE TELEHEALTH MARKET: BY DELIVERY MODE, 2024-2031 (USD MILLION)
FIGURE 21 EUROPE TELEHEALTH MARKET: BY DELIVERY MODE, CAGR (2024-2031)
FIGURE 22 EUROPE TELEHEALTH MARKET: BY DELIVERY MODE, LIFELINE CURVE
FIGURE 23 EUROPE TELEHEALTH MARKET: BY MODE OF PURCHASE, 2023
FIGURE 24 EUROPE TELEHEALTH MARKET: BY MODE OF PURCHASE, 2024-2031 (USD MILLION)
FIGURE 25 EUROPE TELEHEALTH MARKET: BY MODE OF PURCHASE, CAGR (2024-2031)
FIGURE 26 EUROPE TELEHEALTH MARKET: BY MODE OF PURCHASE, LIFELINE CURVE
FIGURE 27 EUROPE TELEHEALTH MARKET: BY APPLICATION, 2023
FIGURE 28 EUROPE TELEHEALTH MARKET: BY APPLICATION, 2024-2031 (USD MILLION)
FIGURE 29 EUROPE TELEHEALTH MARKET: BY APPLICATION, CAGR (2024-2031)
FIGURE 30 EUROPE TELEHEALTH MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 31 EUROPE TELEHEALTH MARKET: BY END USER, 2023
FIGURE 32 EUROPE TELEHEALTH MARKET: BY END USER, 2024-2031 (USD MILLION)
FIGURE 33 EUROPE TELEHEALTH MARKET: BY END USER, CAGR (2024-2031)
FIGURE 34 EUROPE TELEHEALTH MARKET, BY END USER, LIFELINE CURVE
FIGURE 35 EUROPE TELEHEALTH MARKET: SNAPSHOT (2023)
FIGURE 36 EUROPE TELEHEALTH MARKET: COMPANY SHARE 2023 (%)
Forschungsmethodik
Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.
Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.
Anpassung möglich
Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.
